What is the clinical grading system for acanthosis nigricans?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Grading of Acanthosis Nigricans

The most validated and clinically useful grading system for acanthosis nigricans is the quantitative neck-based scale developed by Burke et al., which grades severity from 0-4 based on both the extent of neck involvement and texture changes, with the neck being the most reliable anatomic site for assessment 1.

Primary Grading System

The Burke scale focuses specifically on neck involvement because this site demonstrates the highest interobserver reliability (high kappa statistics) compared to other anatomic locations 1. Other sites like axilla, elbows, knuckles, and knees showed inconsistent reliability and were excluded from the validated scale.

Neck Severity Grading (0-4 scale):

  • Grade 0: Absent
  • Grade 1: Present but mild
  • Grade 2: Moderate
  • Grade 3: Severe
  • Grade 4: Very severe

The grading considers both:

  • Surface area involvement on the neck
  • Texture changes (papillomatous/verrucous thickening)

Clinical Significance of Grading

The severity of acanthosis nigricans correlates most strongly with insulin resistance (r = -0.61, P < 0.001) rather than with insulin levels or androgen levels alone 2. This makes the grading system clinically valuable for:

  • Identifying patients at risk for metabolic syndrome (78.3% of AN patients have metabolic syndrome) 3
  • Predicting insulin resistance severity
  • Monitoring metabolic risk factors

Key Anatomic Sites to Examine:

  1. Neck (most reliable for grading) - should always be documented
  2. Axilla (85% involvement) - axillary severity correlates with metabolic syndrome (P = 0.001) 3
  3. Knuckles (55% involvement) - predicts liver steatosis (OR 2.09) 4
  4. Elbows, knees, groin - less commonly involved

Alternative Comprehensive Scoring System

For research purposes, the SCANS (Scoring for Acanthosis Nigricans Severity) evaluates six anatomic sites with scores ranging from 0-46, incorporating 5:

  • Affected skin surface area
  • Texture changes
  • Number of skin tags

However, this system is more complex and primarily used in research settings rather than routine clinical practice.

Documentation Requirements

At diagnosis, document 6:

  • Location using a body diagram
  • Grade/thickness (grade 1,2, or 3 terminology is acceptable)
  • Presence of skin tags (correlates with AN severity, r = 0.132, P < 0.001) 5

Critical Clinical Pitfall

Clinical examination alone is highly insensitive - one study found that while AN was clinically detected in only 11 of 13 obese patients, histological examination revealed AN in all 13 patients 2. However, histological confirmation is not required for routine clinical diagnosis and grading.

Practical Application

Use the neck-based 0-4 grading system in clinical practice because:

  • Highest interobserver reliability
  • Strongest correlation with insulin resistance
  • Easy to perform and document
  • Validated in multiple populations 1

The presence and severity of neck AN should trigger metabolic screening for diabetes, insulin resistance, and metabolic syndrome, as the neck texture grading specifically correlates with insulin resistance (P = 0.005) 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.